Determination of picropodophyllin and its isomer podophyllotoxin in human serum samples with electrospray ionization of hexylamine adducts by liquid chromatography–tandem mass spectrometry
A liquid chromatography–tandem mass spectrometry (LC–MS/MS) method for determination of the new anticancer agent picropodophyllin (AXL1717) and its isomer podophyllotoxin levels in human serum has been developed. Monitoring of hexylamine adducts rather than proton adducts was used to optimize sensit...
Saved in:
Published in | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences Vol. 879; no. 5; pp. 326 - 334 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Amsterdam
Elsevier B.V
15.02.2011
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | A liquid chromatography–tandem mass spectrometry (LC–MS/MS) method for determination of the new anticancer agent picropodophyllin (AXL1717) and its isomer podophyllotoxin levels in human serum has been developed. Monitoring of hexylamine adducts rather than proton adducts was used to optimize sensitivity. The chromatography system was an Acquity BEH C18, 2.1
mm
×
50
mm 1.7
μm column with gradient elution (mobile phase A: 2.5
mM hexylamine and 5
mM formic acid in Milli-Q water and mobile phase B: methanol). The retention times were 1.4
min for picropodophyllin, 1.5
min for podophyllotoxin and 1.9
min for internal standard deoxypodophyllotoxin. The isomers were base-line separated. The analytes were detected after electrospray ionization in positive mode with selected reaction monitoring (SRM) with ion transitions
m/
z 516
→
102 for picropodophyllin and podophyllotoxin and
m/
z 500
→
102 for internal standard. The sample preparation was protein precipitation with acetonitrile (1:3) containing internal standard followed by dilution of the supernatant with mobile phase A (1:1). The limit of quantification (LOQ) was 0.01
μmol/L for picropodophyllin and podophyllotoxin. The limit of detection (LOD) at 3 times the signal to noise (S/N) was estimated below 0.001
μmol/L for picropodophyllin and podophyllotoxin. The quantification range of the method was between 0.01
μmol/L and 5
μmol/L for both isomers. The accuracy was within ±15% of the theoretical value for both picropodophyllin and podophyllotoxin and inter-assay precision did not exceed ±15%, except for the 0.016
μmol/L level of podophyllotoxin, which was 18%. The selectivity of the method was verified by analysis of two different product ions for each analyte and by analysis for interference of seven different batches of blank human serum. The combined recovery and matrix effects were about 83% for picropodophyllin and podophyllotoxin. The new LC–MS/MS method showed sufficient sensitivity and selectivity for determination of picropodophyllin and its isomer podophyllotoxin levels in human serum from subjects receiving therapeutic doses of AXL1717. |
---|---|
AbstractList | A liquid chromatography–tandem mass spectrometry (LC–MS/MS) method for determination of the new anticancer agent picropodophyllin (AXL1717) and its isomer podophyllotoxin levels in human serum has been developed. Monitoring of hexylamine adducts rather than proton adducts was used to optimize sensitivity. The chromatography system was an Acquity BEH C18, 2.1mm×50mm 1.7μm column with gradient elution (mobile phase A: 2.5mM hexylamine and 5mM formic acid in Milli-Q water and mobile phase B: methanol). The retention times were 1.4min for picropodophyllin, 1.5min for podophyllotoxin and 1.9min for internal standard deoxypodophyllotoxin. The isomers were base-line separated. The analytes were detected after electrospray ionization in positive mode with selected reaction monitoring (SRM) with ion transitions m/z 516→102 for picropodophyllin and podophyllotoxin and m/z 500→102 for internal standard. The sample preparation was protein precipitation with acetonitrile (1:3) containing internal standard followed by dilution of the supernatant with mobile phase A (1:1). The limit of quantification (LOQ) was 0.01μmol/L for picropodophyllin and podophyllotoxin. The limit of detection (LOD) at 3 times the signal to noise (S/N) was estimated below 0.001μmol/L for picropodophyllin and podophyllotoxin. The quantification range of the method was between 0.01μmol/L and 5μmol/L for both isomers. The accuracy was within ±15% of the theoretical value for both picropodophyllin and podophyllotoxin and inter-assay precision did not exceed ±15%, except for the 0.016μmol/L level of podophyllotoxin, which was 18%. The selectivity of the method was verified by analysis of two different product ions for each analyte and by analysis for interference of seven different batches of blank human serum. The combined recovery and matrix effects were about 83% for picropodophyllin and podophyllotoxin. The new LC–MS/MS method showed sufficient sensitivity and selectivity for determination of picropodophyllin and its isomer podophyllotoxin levels in human serum from subjects receiving therapeutic doses of AXL1717. A liquid chromatography–tandem mass spectrometry (LC–MS/MS) method for determination of the new anticancer agent picropodophyllin (AXL1717) and its isomer podophyllotoxin levels in human serum has been developed. Monitoring of hexylamine adducts rather than proton adducts was used to optimize sensitivity. The chromatography system was an Acquity BEH C18, 2.1 mm × 50 mm 1.7 μm column with gradient elution (mobile phase A: 2.5 mM hexylamine and 5 mM formic acid in Milli-Q water and mobile phase B: methanol). The retention times were 1.4 min for picropodophyllin, 1.5 min for podophyllotoxin and 1.9 min for internal standard deoxypodophyllotoxin. The isomers were base-line separated. The analytes were detected after electrospray ionization in positive mode with selected reaction monitoring (SRM) with ion transitions m/ z 516 → 102 for picropodophyllin and podophyllotoxin and m/ z 500 → 102 for internal standard. The sample preparation was protein precipitation with acetonitrile (1:3) containing internal standard followed by dilution of the supernatant with mobile phase A (1:1). The limit of quantification (LOQ) was 0.01 μmol/L for picropodophyllin and podophyllotoxin. The limit of detection (LOD) at 3 times the signal to noise (S/N) was estimated below 0.001 μmol/L for picropodophyllin and podophyllotoxin. The quantification range of the method was between 0.01 μmol/L and 5 μmol/L for both isomers. The accuracy was within ±15% of the theoretical value for both picropodophyllin and podophyllotoxin and inter-assay precision did not exceed ±15%, except for the 0.016 μmol/L level of podophyllotoxin, which was 18%. The selectivity of the method was verified by analysis of two different product ions for each analyte and by analysis for interference of seven different batches of blank human serum. The combined recovery and matrix effects were about 83% for picropodophyllin and podophyllotoxin. The new LC–MS/MS method showed sufficient sensitivity and selectivity for determination of picropodophyllin and its isomer podophyllotoxin levels in human serum from subjects receiving therapeutic doses of AXL1717. A liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for determination of the new anticancer agent picropodophyllin (AXL1717) and its isomer podophyllotoxin levels in human serum has been developed. Monitoring of hexylamine adducts rather than proton adducts was used to optimize sensitivity. The chromatography system was an Acquity BEH C18, 2.1 mm × 50 mm 1.7 μm column with gradient elution (mobile phase A: 2.5 mM hexylamine and 5 mM formic acid in Milli-Q water and mobile phase B: methanol). The retention times were 1.4 min for picropodophyllin, 1.5 min for podophyllotoxin and 1.9 min for internal standard deoxypodophyllotoxin. The isomers were base-line separated. The analytes were detected after electrospray ionization in positive mode with selected reaction monitoring (SRM) with ion transitions m/z 516→102 for picropodophyllin and podophyllotoxin and m/z 500→102 for internal standard. The sample preparation was protein precipitation with acetonitrile (1:3) containing internal standard followed by dilution of the supernatant with mobile phase A (1:1). The limit of quantification (LOQ) was 0.01 μmol/L for picropodophyllin and podophyllotoxin. The limit of detection (LOD) at 3 times the signal to noise (S/N) was estimated below 0.001 μmol/L for picropodophyllin and podophyllotoxin. The quantification range of the method was between 0.01 μmol/L and 5 μmol/L for both isomers. The accuracy was within ±15% of the theoretical value for both picropodophyllin and podophyllotoxin and inter-assay precision did not exceed ±15%, except for the 0.016 μmol/L level of podophyllotoxin, which was 18%. The selectivity of the method was verified by analysis of two different product ions for each analyte and by analysis for interference of seven different batches of blank human serum. The combined recovery and matrix effects were about 83% for picropodophyllin and podophyllotoxin. The new LC-MS/MS method showed sufficient sensitivity and selectivity for determination of picropodophyllin and its isomer podophyllotoxin levels in human serum from subjects receiving therapeutic doses of AXL1717.A liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for determination of the new anticancer agent picropodophyllin (AXL1717) and its isomer podophyllotoxin levels in human serum has been developed. Monitoring of hexylamine adducts rather than proton adducts was used to optimize sensitivity. The chromatography system was an Acquity BEH C18, 2.1 mm × 50 mm 1.7 μm column with gradient elution (mobile phase A: 2.5 mM hexylamine and 5 mM formic acid in Milli-Q water and mobile phase B: methanol). The retention times were 1.4 min for picropodophyllin, 1.5 min for podophyllotoxin and 1.9 min for internal standard deoxypodophyllotoxin. The isomers were base-line separated. The analytes were detected after electrospray ionization in positive mode with selected reaction monitoring (SRM) with ion transitions m/z 516→102 for picropodophyllin and podophyllotoxin and m/z 500→102 for internal standard. The sample preparation was protein precipitation with acetonitrile (1:3) containing internal standard followed by dilution of the supernatant with mobile phase A (1:1). The limit of quantification (LOQ) was 0.01 μmol/L for picropodophyllin and podophyllotoxin. The limit of detection (LOD) at 3 times the signal to noise (S/N) was estimated below 0.001 μmol/L for picropodophyllin and podophyllotoxin. The quantification range of the method was between 0.01 μmol/L and 5 μmol/L for both isomers. The accuracy was within ±15% of the theoretical value for both picropodophyllin and podophyllotoxin and inter-assay precision did not exceed ±15%, except for the 0.016 μmol/L level of podophyllotoxin, which was 18%. The selectivity of the method was verified by analysis of two different product ions for each analyte and by analysis for interference of seven different batches of blank human serum. The combined recovery and matrix effects were about 83% for picropodophyllin and podophyllotoxin. The new LC-MS/MS method showed sufficient sensitivity and selectivity for determination of picropodophyllin and its isomer podophyllotoxin levels in human serum from subjects receiving therapeutic doses of AXL1717. A liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for determination of the new anticancer agent picropodophyllin (AXL1717) and its isomer podophyllotoxin levels in human serum has been developed. Monitoring of hexylamine adducts rather than proton adducts was used to optimize sensitivity. The chromatography system was an Acquity BEH C18, 2.1 mm x 50 mm 1.7 mu m column with gradient elution (mobile phase A: 2.5 mM hexylamine and 5 mM formic acid in Milli-Q water and mobile phase B: methanol). The retention times were 1.4 min for picropodophyllin, 1.5 min for podophyllotoxin and 1.9 min for internal standard deoxypodophyllotoxin. The isomers were base-line separated. The analytes were detected after electrospray ionization in positive mode with selected reaction monitoring (SRM) with ion transitions m/z 516 --> 102 for picropodophyllin and podophyllotoxin and m/z 500 --> 102 for internal standard. The sample preparation was protein precipitation with acetonitrile (1:3) containing internal standard followed by dilution of the supernatant with mobile phase A (1:1). The limit of quantification (LOQ) was 0.01 mu mol/L for picropodophyllin and podophyllotoxin. The limit of detection (LOD) at 3 times the signal to noise (S/N) was estimated below 0.001 mu mol/L for picropodophyllin and podophyllotoxin. The quantification range of the method was between 0.01 mu mol/L and 5 mu mol/L for both isomers. The accuracy was within +/-15% of the theoretical value for both picropodophyllin and podophyllotoxin and inter-assay precision did not exceed +/-15%, except for the 0.016 mu mol/L level of podophyllotoxin, which was 18%. The selectivity of the method was verified by analysis of two different product ions for each analyte and by analysis for interference of seven different batches of blank human serum. The combined recovery and matrix effects were about 83% for picropodophyllin and podophyllotoxin. The new LC-MS/MS method showed sufficient sensitivity and selectivity for determination of picropodophyllin and its isomer podophyllotoxin levels in human serum from subjects receiving therapeutic doses of AXL1717. A liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for determination of the new anticancer agent picropodophyllin (AXL1717) and its isomer podophyllotoxin levels in human serum has been developed. Monitoring of hexylamine adducts rather than proton adducts was used to optimize sensitivity. The chromatography system was an Acquity BEN C18, 2.1 mm x 50 mm 1.7 mu m column with gradient elution (mobile phase A: 2.5 mM hexylamine and 5 mM formic acid in Milli-Qwater and mobile phase B: methanol). The retention times were 1.4 min for picropodophyllin, 1.5 min for podophyllotoxin and 1.9 min for internal standard deoxypodophyllotoxin. The isomers were base-line separated. The analytes were detected after electrospray ionization in positive mode with selected reaction monitoring (SRM) with ion transitions m/z 516 --> 102 for picropodophyllin and podophyllotoxin and m/z 500 --> 102 for internal standard. The sample preparation was protein precipitation with acetonitrile (1:3) containing internal standard followed by dilution of the supernatant with mobile phase A (1:1). The limit of quantification (LOQ) was 0.01 mu mol/L for picropodophyllin and podophyllotoxin. The limit of detection (LOD) at 3 times the signal to noise (S/N) was estimated below 0.001 mu mol/L for picropodophyllin and podophyllotoxin. The quantification range of the method was between 0.01 mu mol/L and 5 mu mol/L for both isomers. The accuracy was within +/-15% of the theoretical value for both picropodophyllin and podophyllotoxin and inter-assay precision did not exceed +/-15%, except for the 0.016 mu mol/L level of podophyllotoxin, which was 18%. The selectivity of the method was verified by analysis of two different product ions for each analyte and by analysis for interference of seven different batches of blank human serum. The combined recovery and matrix effects were about 83% for picropodophyllin and podophyllotoxin. The new LC-MS/MS method showed sufficient sensitivity and selectivity for determination of picropodophyllin and its isomer podophyllotoxin levels in human serum from subjects receiving therapeutic doses of AXL1717. A liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for determination of the new anticancer agent picropodophyllin (AXL1717) and its isomer podophyllotoxin levels in human serum has been developed. Monitoring of hexylamine adducts rather than proton adducts was used to optimize sensitivity. The chromatography system was an Acquity BEH C18, 2.1 mm × 50 mm 1.7 μm column with gradient elution (mobile phase A: 2.5 mM hexylamine and 5 mM formic acid in Milli-Q water and mobile phase B: methanol). The retention times were 1.4 min for picropodophyllin, 1.5 min for podophyllotoxin and 1.9 min for internal standard deoxypodophyllotoxin. The isomers were base-line separated. The analytes were detected after electrospray ionization in positive mode with selected reaction monitoring (SRM) with ion transitions m/z 516→102 for picropodophyllin and podophyllotoxin and m/z 500→102 for internal standard. The sample preparation was protein precipitation with acetonitrile (1:3) containing internal standard followed by dilution of the supernatant with mobile phase A (1:1). The limit of quantification (LOQ) was 0.01 μmol/L for picropodophyllin and podophyllotoxin. The limit of detection (LOD) at 3 times the signal to noise (S/N) was estimated below 0.001 μmol/L for picropodophyllin and podophyllotoxin. The quantification range of the method was between 0.01 μmol/L and 5 μmol/L for both isomers. The accuracy was within ±15% of the theoretical value for both picropodophyllin and podophyllotoxin and inter-assay precision did not exceed ±15%, except for the 0.016 μmol/L level of podophyllotoxin, which was 18%. The selectivity of the method was verified by analysis of two different product ions for each analyte and by analysis for interference of seven different batches of blank human serum. The combined recovery and matrix effects were about 83% for picropodophyllin and podophyllotoxin. The new LC-MS/MS method showed sufficient sensitivity and selectivity for determination of picropodophyllin and its isomer podophyllotoxin levels in human serum from subjects receiving therapeutic doses of AXL1717. |
Author | Beck, Olof Axelson, Magnus Eksborg, Staffan Rönquist-Nii, Yuko Harmenberg, Johan |
Author_xml | – sequence: 1 givenname: Yuko surname: Rönquist-Nii fullname: Rönquist-Nii, Yuko email: yuko.ronquist@karolinska.se organization: Department of Clinical Pharmacology, Karolinska University Hospital, SE-141 86 Stockholm, Sweden – sequence: 2 givenname: Staffan surname: Eksborg fullname: Eksborg, Staffan organization: Karolinska Institutet, Stockholm, Sweden – sequence: 3 givenname: Magnus surname: Axelson fullname: Axelson, Magnus organization: Department of Clinical Chemistry, Karolinska University Hospital, Stockholm, Sweden – sequence: 4 givenname: Johan surname: Harmenberg fullname: Harmenberg, Johan organization: Axelar AB, Karolinska Institutet Science Park, SE-171 65 Solna, Sweden – sequence: 5 givenname: Olof surname: Beck fullname: Beck, Olof organization: Department of Clinical Pharmacology, Karolinska University Hospital, SE-141 86 Stockholm, Sweden |
BackLink | https://cir.nii.ac.jp/crid/1572543024858732032$$DView record in CiNii http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23877291$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/21251888$$D View this record in MEDLINE/PubMed https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-173947$$DView record from Swedish Publication Index http://kipublications.ki.se/Default.aspx?queryparsed=id:122017788$$DView record from Swedish Publication Index |
BookMark | eNqFkttu1DAQhiNURA_wCIAvQHDBLj7EjldcoKrlJFXigoK4sxxn0vWSxKmd0C5XvAPvw8PwJMweWiQkqBQ5lv3N_OOZfz_b6UIHWXaf0SmjTD1fTBduHkNbTjldnfEpZcWtbI_pQkxEoT7v4F4WdEK54LvZfkoLigQtxJ1slzMumdZ6L_t5DAPE1nd28KEjoSa9dzH0oQr9fNk0viO2q4gfEvEptBDJ9VUYwiVe4zcfW9uRBHFsSbJt30AiF36YE2jADTGkPtolwfz-27XMHC6XjUVhILaqRocC5ZI0_nz0FVm_zA7hLFqU-vX9x4BFQEtamxJJ_TppC0Nc3s1u17ZJcG_7P8hOX786PXo7OXn_5t3R4cnESV0ME1s7KBUtK61y7ljtZpLrAoqcY4t0XVYsB8ehsppJcFBLauuSsVLNnKQ1EwfZZJM2XUA_lqaPvrVxaYL1Znv0BXdgZK4UFcg_-yd_7D8dmhDPzDgaVohZXiD-ZIP3MZyPkAbT-uSgaWwHYUxGKyaVRvRmUlKpBBernE__SzKlhBIy1xTRB1t0LFuorqu9cgkCj7eATc42dbSd8-kPJ3RR8NmqTS82HDoopQi1cX5YT3yI1jeGUbPyrlmYrXfNyruGcYPOxGj5V_SVwE1xjzZxnfcouFpxqlzmgvJc4_wFp9iSg-zhBqttMPYs4gM-fsA8klJaKLZu7ssNAeikrx6iSc5D56DyES1nquBvKOU3Djgneg |
CitedBy_id | crossref_primary_10_1002_slct_202305100 crossref_primary_10_1016_j_molliq_2020_114258 crossref_primary_10_1021_acs_chemrev_8b00504 crossref_primary_10_1158_1535_7163_MCT_13_0091 crossref_primary_10_1002_bmc_3066 crossref_primary_10_1016_j_jelechem_2020_114439 crossref_primary_10_3109_0284186X_2015_1049290 crossref_primary_10_1016_j_jct_2021_106668 crossref_primary_10_1039_C4NP00064A crossref_primary_10_3390_cancers12040793 |
ContentType | Journal Article |
Copyright | 2010 Elsevier B.V. 2015 INIST-CNRS Copyright © 2010 Elsevier B.V. All rights reserved. |
Copyright_xml | – notice: 2010 Elsevier B.V. – notice: 2015 INIST-CNRS – notice: Copyright © 2010 Elsevier B.V. All rights reserved. |
DBID | FBQ RYH AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7S9 L.6 7X8 7TB 8FD FR3 ADTPV AOWAS DF2 |
DOI | 10.1016/j.jchromb.2010.12.017 |
DatabaseName | AGRIS CiNii Complete CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed AGRICOLA AGRICOLA - Academic MEDLINE - Academic Mechanical & Transportation Engineering Abstracts Technology Research Database Engineering Research Database SwePub SwePub Articles SWEPUB Uppsala universitet |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AGRICOLA AGRICOLA - Academic MEDLINE - Academic Technology Research Database Mechanical & Transportation Engineering Abstracts Engineering Research Database |
DatabaseTitleList | MEDLINE - Academic Technology Research Database MEDLINE AGRICOLA |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: FBQ name: AGRIS url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN sourceTypes: Publisher |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology Chemistry |
EISSN | 1873-376X |
EndPage | 334 |
ExternalDocumentID | oai_swepub_ki_se_546603 oai_DiVA_org_uu_173947 21251888 23877291 10_1016_j_jchromb_2010_12_017 10029516781 US201500076194 S1570023210007737 |
Genre | Journal Article |
GroupedDBID | --K --M .GJ .~1 0R~ 1B1 1RT 1~. 1~5 29K 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 8P~ AABNK AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AARLI AAXUO ABFNM ABFRF ABGSF ABJNI ABMAC ABUDA ABXDB ABYKQ ACDAQ ACGFS ACNNM ACRLP ADBBV ADECG ADEZE ADUVX AEBSH AEFWE AEHWI AEKER AFKWA AFTJW AFXIZ AFZHZ AGHFR AGRDE AGUBO AGYEJ AI. AIEXJ AIKHN AITUG AJBFU AJOXV AJSZI ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ AXJTR BKOJK BLXMC CS3 D-I DOVZS EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FIRID FLBIZ FNPLU FYGXN G-Q GBLVA HVGLF HZ~ IHE J1W KOM M41 MO0 N9A NCXOZ O-L O9- OAUVE OHT OZT P-8 P-9 PC. Q38 RIG RNS ROL RPZ SCB SCC SDF SDG SDP SES SEW SPC SPCBC SSK SSU SSZ T5K VH1 XFK ZGI ~G- AATTM AAXKI AEIPS AFJKZ ANKPU BNPGV FBQ SSH AAYWO AGCQF AGRNS AIIUN RYH AAYXX CITATION APXCP EFKBS IQODW CGR CUY CVF ECM EIF NPM 7S9 L.6 7X8 7TB 8FD FR3 ADTPV AOWAS DF2 |
ID | FETCH-LOGICAL-c587t-afceb60bd8642c1fc95287e7421578fbd14ec2eda815ecef50afb11b69c50f13 |
IEDL.DBID | .~1 |
ISSN | 1570-0232 1873-376X |
IngestDate | Mon Sep 01 03:36:11 EDT 2025 Thu Aug 21 06:28:52 EDT 2025 Fri Jul 11 16:13:58 EDT 2025 Tue Aug 05 11:13:15 EDT 2025 Thu Jul 10 22:20:30 EDT 2025 Mon Jul 21 05:52:07 EDT 2025 Mon Jul 21 09:14:16 EDT 2025 Tue Jul 01 01:50:04 EDT 2025 Thu Apr 24 22:51:21 EDT 2025 Thu Jun 26 23:27:42 EDT 2025 Thu Apr 03 09:44:09 EDT 2025 Fri Feb 23 02:21:37 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | Human serum Hexylamine adduct LC–MS/MS Picropodophyllin Antineoplastic agent Human Biological fluid Podophyllotoxin HPLC chromatography Determination Electrospray Isomer Mass spectrometry MS/MS LC―MS/MS Lignan Hexylamine Antimitotic Molecular adduct Quantitative analysis |
Language | English |
License | https://www.elsevier.com/tdm/userlicense/1.0 CC BY 4.0 Copyright © 2010 Elsevier B.V. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c587t-afceb60bd8642c1fc95287e7421578fbd14ec2eda815ecef50afb11b69c50f13 |
Notes | http://dx.doi.org/10.1016/j.jchromb.2010.12.017 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
PMID | 21251888 |
PQID | 1663635480 |
PQPubID | 24069 |
PageCount | 9 |
ParticipantIDs | swepub_primary_oai_swepub_ki_se_546603 swepub_primary_oai_DiVA_org_uu_173947 proquest_miscellaneous_861568394 proquest_miscellaneous_850563237 proquest_miscellaneous_1663635480 pubmed_primary_21251888 pascalfrancis_primary_23877291 crossref_citationtrail_10_1016_j_jchromb_2010_12_017 crossref_primary_10_1016_j_jchromb_2010_12_017 nii_cinii_1572543024858732032 fao_agris_US201500076194 elsevier_sciencedirect_doi_10_1016_j_jchromb_2010_12_017 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2011-02-15 |
PublicationDateYYYYMMDD | 2011-02-15 |
PublicationDate_xml | – month: 02 year: 2011 text: 2011-02-15 day: 15 |
PublicationDecade | 2010 |
PublicationPlace | Amsterdam |
PublicationPlace_xml | – name: Amsterdam – name: Netherlands |
PublicationTitle | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences |
PublicationTitleAlternate | J Chromatogr B Analyt Technol Biomed Life Sci |
PublicationYear | 2011 |
Publisher | Elsevier B.V Elsevier |
Publisher_xml | – name: Elsevier B.V – name: Elsevier |
References | Gualberto, Pollak (bib0010) 2009; 10 Zhao, Liu, Fan (bib0020) 2009; 32 Tashima, Kondo, Meada, Oda, Hagimoto, Tsukuda, Yushimura (bib0045) 2002; 37 Razuvaev, Henderson, Girnita, Larsson, Axelson, Hedin, Roy (bib0025) 2007; 46 Gao, Zhang, Karnes (bib0040) 2005; 825 Mortier, Zhang, Van Peterghem, Lambert (bib0050) 2004; 15 Pollak (bib0015) 2008; 8 Shah, Midha, Findlay, Hill, Hulse, McGilveray, McKay, Miller, Patnailk, Powell, Tonelli, Viswanathan, Yacobi (bib0030) 2000; 825 Food Drug Administration (bib0035) 2001 Girnita, Girnita, del Prete, Bartolazzi, Larsson, Axelson (bib0005) 2004; 64 Stefansson, Sjöberg, Markides (bib0055) 1996; 68 J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Mar 15;889-890:148 |
References_xml | – year: 2001 ident: bib0035 article-title: Guidance for Industry: Bioanalytical Methods Validation – volume: 46 start-page: 108 year: 2007 ident: bib0025 publication-title: J. Vasc. Surg. – volume: 32 start-page: 1323 year: 2009 ident: bib0020 publication-title: J. Sep. Sci. – volume: 37 start-page: 631 year: 2002 ident: bib0045 publication-title: J. Mass Spectrom. – volume: 68 start-page: 1792 year: 1996 ident: bib0055 publication-title: Anal. Chem. – volume: 10 start-page: 923 year: 2009 ident: bib0010 publication-title: Curr. Drug Targets – volume: 825 start-page: 1551 year: 2000 ident: bib0030 publication-title: Pharmaceut. Res. B – volume: 15 start-page: 585 year: 2004 ident: bib0050 publication-title: J. Am. Soc. Mass Spectrom. – volume: 8 start-page: 915 year: 2008 ident: bib0015 publication-title: Nat. Rev. Cancer – volume: 825 start-page: 98 year: 2005 ident: bib0040 publication-title: J. Chromatogr. B – volume: 64 start-page: 236 year: 2004 ident: bib0005 publication-title: Cancer Res. – reference: - J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Mar 15;889-890:148 |
SSID | ssj0017073 |
Score | 2.0416338 |
Snippet | A liquid chromatography–tandem mass spectrometry (LC–MS/MS) method for determination of the new anticancer agent picropodophyllin (AXL1717) and its isomer... A liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for determination of the new anticancer agent picropodophyllin (AXL1717) and its isomer... |
SourceID | swepub proquest pubmed pascalfrancis crossref nii fao elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 326 |
SubjectTerms | acetonitrile Adducts Adult Aged, 80 and over Amines Amines - chemistry analogs & derivatives Analysis Analytical, structural and metabolic biochemistry Animals antineoplastic agents Biological and medical sciences blood blood serum chemistry Chromatography Chromatography, Liquid Chromatography, Liquid - methods detection limit Drug Stability Female formic acid Fundamental and applied biological sciences. Psychology General pharmacology Hexylamine adduct Human Human serum Humans Ionization ions Isomers LC-MS LC–MS/MS Least-Squares Analysis liquid chromatography Liquids Male Medical sciences methanol methods Mice monitoring pharmacokinetics Pharmacology. Drug treatments Picropodophyllin Podophyllotoxin Podophyllotoxin - analogs & derivatives Podophyllotoxin - analysis Podophyllotoxin - blood Podophyllotoxin - pharmacokinetics Reproducibility of Results Sensitivity and Specificity Serums Spectrometry, Mass, Electrospray Ionization Spectrometry, Mass, Electrospray Ionization - methods Swine Tandem Mass Spectrometry |
Title | Determination of picropodophyllin and its isomer podophyllotoxin in human serum samples with electrospray ionization of hexylamine adducts by liquid chromatography–tandem mass spectrometry |
URI | https://dx.doi.org/10.1016/j.jchromb.2010.12.017 https://cir.nii.ac.jp/crid/1572543024858732032 https://www.ncbi.nlm.nih.gov/pubmed/21251888 https://www.proquest.com/docview/1663635480 https://www.proquest.com/docview/850563237 https://www.proquest.com/docview/861568394 https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-173947 http://kipublications.ki.se/Default.aspx?queryparsed=id:122017788 |
Volume | 879 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbGeOEFAQMWYJWRYG9Z41zdx6pjKhdNiG1ob1bi2Fu6JSm5SCsPiP_A_-HH8Es4J7dpqDAJqUorX2rX_nr8-fj4HEJeBR5TtiUd0_NVbLrSluYklpHJYbEINHB8pRoD2UN_fuK-O_VON8isvwuDZpWd7G9leiOtu5RxN5rjZZKMjxi6ZrfxDgr6pHHwRrnrBojyvW-DmQcLrOaUGQubWPr6Fs94sbeQ50WeRq2FF2oFm7hla9enOzrM4ZklCZpPhiWMoG5DX6zjpn84Hm0Wq4MH5H7HMum0_SEPyYbKHpGtaQY77HRFd2lj99ko1LfIz_3eIgbniOaaLtFIbwn7VZgCdNlNwyymSVXSpMxTVdAhK6_yK8iGVxPqjwKc65SWIXocLimqeGkXZqdcFuGKou7369DMubpaAR6B5lIQf7WEBqIVvUy-1ElMmyGD7rYOtX99_4EqD5XSFMg-ba6Hop-Fqlg9JscHb45nc7OL6mBKjweVGWqpIt-KYg5bH8m0nHiwa1OwRYc54jqKmaukreKQM09JpT0r1BFjkT-RnqWZ84RsZnmmtgnVStkxgC2EdFfG3kTG2ouQUk78UHNlELefSiE7j-cYeONS9KZtC9EhQCACBLMFIMAge0O1Zevy47YKvMeJuIFdAcvSbVW3AVciPAOJLk6ObNQ_Wa1qySA7ADboOD5haNBrQeOAjgcOhr03yOgGDIe-AgnDLRMzyMselwJkBh4EhZnK61IwoJlANF1uGYT-pQxHauzYTvCPIsCGfSDY0NWnLeyv-4C8mXNukNft_2DIQXfm-8nnqciLM1HXggXwBdDI7ppyXdIFfFLCc33fcp79_1g_J_faAwHbZN4LslkVtdoBRllFo0ZkjMjd6ezTh4_4_vb9_PA3aFZ9Pw |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dbtMwFLa27gJuEDBgATaMBLvLGidx4l5WG1PHRm-2od1ZiWNvKWtSmkRaueIdeB8ehifhnPx0GipMQqqiyrET1_56_Pn4-DMh70LOtOsoz-aBTmxfucoeJCq2BQwWoQGOr3UdIDsORuf-xwt-sUb2u70wGFbZ2v7GptfWuk3pt63Zn6Vp_5ShNLuLe1BQk8YL18kGqlPxHtkYHh2PxsvFhNCpF5oxv40Fbjfy9Cd7E3U1z6dxE-SFjsH66LKVQ9S6iXK4ZmmKEZRRAY1omtMvVtHTP7RH6_Hq8DF51BJNOmx-yxOyprOnZHOYwSR7uqC7tA79rH3qm-TnQRcUg91Ec0NnGKc3gykr9AKqdtMoS2haFjQt8qme0-WtvMxv4DZ86tP-KCC6mtIiQtHhgqKXl7Yn7RSzebSg6P79tnzNlb5ZACSB6VKwgJWCF8QLep1-rdKE1k0G1W00tX99_4FeDz2lU-D7tN4hilIL5XzxjJwdfjjbH9ntwQ624iIs7cgoHQdOnAiY_Shm1IDDxE3DLB36SJg4Yb5Wrk4iwbhW2nAnMjFjcTBQ3DHMe056WZ7pLUKN1m4CeIsg3VcJH6jE8BhZ5SCIjNAW8buulKoVPcezN65lF902kS0CJCJAMlcCAiyytyw2a1Q_7isgOpzIO_CVMDLdV3QLcCWjSzDq8vzURReU03iXLLINYIOK4xWaBoULag06EXqu47kW2bkDw2VdgYfhrIlZ5G2HSwlmA9eCokznVSEZME3gmr5wLEL_kkcgO_ZcL_xHFiDEAXBsqOqLBva3dUDqLISwyPvmf7C8g4rmB-nnocznl7KqJAvhAfCS3RX52qQv8E1L7geB4738_7Z-Qx6Mzj6dyJOj8fEr8rBZH3Btxl-TXjmv9DYQzDLeaQ3Ibzshfls |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Determination+of+picropodophyllin+and+its+isomer+podophyllotoxin+in+human+serum+samples+with+electrospray+ionization+of+hexylamine+adducts+by+liquid+chromatography-tandem+mass+spectrometry&rft.jtitle=Journal+of+chromatography.+B%2C+Analytical+technologies+in+the+biomedical+and+life+sciences&rft.au=Ronquist-Nii%2C+Y&rft.au=Eksborg%2C+S&rft.au=Axelson%2C+M&rft.au=Harmenberg%2C+J&rft.date=2011-02-15&rft.issn=1570-0232&rft.volume=879&rft.issue=5-6&rft.spage=326&rft_id=info:doi/10.1016%2Fj.jchromb.2010.12.017&rft.externalDocID=oai_swepub_ki_se_546603 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1570-0232&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1570-0232&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1570-0232&client=summon |